Your provider should discuss realistic expectations: GLP-1 may not cause significant weight loss in non-overweight patients, but benefitsimproved glucose control, cardiovascular protection, reduced inflammationremain clinically meaningful
The timeline for results can vary depending on the individual and the specific peptides being used
If you are weighing up the tablet against the Wegovy injection pen, our detailed comparison of Wegovy tablets vs Wegovy injections covers the practical differences
But chronic, unexplained symptom presentations involving fatigue, brain fog, joint pain, immune fragility are exactly what functional nutrition is designed to address at the root
[DOI] [PMC free article] [PubMed] [Google Scholar] 40.Feng W., Gao C., Bi Y., Wu M., Li P., Shen S., Chen W., Yin T., Zhu D
Orforglipron is currently under FDA review